Owner MOCHIDA PHARMACEUTICAL CO., LTD. KAZUSA DNA RESEARCH INSTITUTE

Inventors FURUSAKO, Shoji; MIZUSHIMA, Seiichi; NEGISHI, Takaaki; NAGASE, Takahiro; OHARA, Osamu

Pub. Number AU-A-2002216401

PCT Pub. Number WO2002/051999

Priority 2000-388739 21.12.00 JP

Filing date 21 December 2001

Wipo publication date 8 July 2002

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 031/713 - Double-stranded nucleic acids or oligonucleotides

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

A61P 017/06 Drugs for dermatological disorders

A61P 017/00 Drugs for dermatological disorders

A61P 013/12 Drugs for disorders of the urinary system

A61P 011/06 Drugs for disorders of the respiratory system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 001/18 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/04 Drugs for disorders of the alimentary tract or the digestive system

C07K 014/47 Peptides having more than 20 amino acids

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61P 031/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology